🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
The main purpose of the study is to find out if, after 4 weeks of dosing, s...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00454298
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
The purpose of this study is to determine the relative abuse potential of r...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00671632
Treatments Being Tested
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
This will be a single-center, randomized, parallel group, multiple dose adm...
Status
Completed
Location
Mayo Clinic
Start Date
2012-03
Trial ID
NCT01523184